Cargill’s Animal Nutrition business and Purac, a subsidiary of CSM, are to collaborate in the development and commercialisation of bio-based animal feed solutions.
These solutions promote stronger growth and better feed conversion in suboptimal conditions in poultry production while at the same time have the potential to significantly reduce the usage of antibiotics. A first commercial product, Aloapur, will reach the market in July of this year.
Under the collaboration, Purac will focus on technology development and production of Aloapur, while Cargill Animal Nutrition’s Provimi business will focus on application development and commercialisation of the product.
Aloapur, developed and patented by Purac, is a bio based animal feed solution for the improvement of the general health of animals. It is based on Lactylates and has been developed for the first time in animal nutrition and has demonstrated to significantly improve growth and feed conversion in poultry and turkey production in particular in suboptimal conditions. The efficacy of Aloapur has been extensively tested and demonstrated in both scientific research as well as actual production farms by Purac and Cargill.
Commercial production will start in July in a newly built production facility at the Purac site in Gorinchem, the Netherlands.
Cargill’s Provimi business will develop the application and offer Aloapur to customers.